![]() |
|
|||
|
|
|
Addressing Metabolic SyndromeMulti-functional nutritional ingredients may stop the progression of metabolic syndrome
Heather Granato
02/26/2008 Continued from page 2 On its own, the amino acid L-carnitine is well-known for the vital role it plays in fat metabolism, working to transport fatty acids into the mitochondria. In a review of the challenges with insulin resistance in obese adults, researchers at the University of Louisville, Ky., cited carnitine as one dietary agent that may help correct problems at the molecular level.43 Animal studies, primarily using the high fructose-fed Wistar rat, have shown L-carnitine may operate on a number of levels in fighting metabolic syndrome. Researchers from Annamalai University, Annamalai Nagar, India, examined the effect of L-carnitine on lipid accumulation and peroxidative damage in skeletal muscle.44 Intervention ameliorated the insulin resistance seen in the fructosefed animals, normalizing oxidative stress levels and avoiding antioxidant depletion. The same researchers reported L-carnitine (300 mg/Kg) could lower blood pressure in rats by increasing nitric oxide availability and providing antioxidant protection,45 and counter progressive renal disturbances seen in this model of metabolic syndrome.46 Conjugated linoleic acid (CLA), like L-carnitine, is known primarily for its influence on weight management, but has multiple functions in the body that position it as a player in the metabolic syndrome area. One of the most recent studies in weight management reported CLA supplementation (3.2 g/d as Tonalin® CL A, from Cognis Nutrition & Health) in a group of 40 healthy, overweight subjects for six months over the holiday season actually improved body composition, reducing body fat.47 While insulin resistance was not affected, there was a decrease in biomarkers of endothelial dysfunction. However, a study out of the University of Alberta, Edmonton, found a combination of CLA and chromium picolinate could reduce food intake, body weight and fasting insulin levels in an animal model, while simultaneously improving vascular function suggesting their usefulness as adjuncts in treatment of met abolic syndrome.48 Japanese researchers found dietary CLA given to obese, diabetic Zucker rats could alter expression of several genes related to lipid metabolism and insulin sensitivity, alleviating insulin resistance and increasing expression of lipolytic genes.49In addition, CLA may work to synergistically enhance the effect of other treatments for metabolic syndrome. Researchers from the University of Manitoba, Winnipeg, examined the effect of the antihypertensive drug, telmisartan, with CLA in a 20- week rat study.50 Co-administration of the drug and nutraceutical resulted in significant reductions in body weight, visceral fat, total cholesterol, triglycerides, plasma insulin concentrations and systolic blood pressure, compared to the control group. Botanicals with Benefits Around the globe and throughout history, traditional healers have turned to the power of botanicals and plants used naturally in the diet to help treat the conflux of issues seen in metabolic syndrome. Consider the role of soy in Asian cultures, serving as the primary source of protein and delivering its host of phytonutrients. Studies have shown greater intake of soy may reduce the risk of diabetes; data from the Shanghai Women’s Health Study found a 50-percent reduction in the risk of developing type 2 diabetes when comparing the highest versus lowest quintiles of soybean intake.51 Research from the same cohort also found a clear dose-response relationship between soyfood intake and risk of coronary heart disease,52 and an inverse relationship between soyfood intake and both systolic and diastolic blood pressure.53 Interestingly, the study also showed a significant association between abdominal adiposity and mortality risk from CVD and diabetes.54 Intervention studies have also shown benefits of including soy in the diet. Researchers at Isfahan University of Medical Sciences, Iran, randomized 42 postmenopausal women with metabolic syndrome to consume a control diet (Dietary Approaches to Stop Hypertension [DASH]), a soy diet (replacing one serving of red meat per day in the DASH diet with soy protein) and soy nut diet (replacing one serving of red meat per day in the DASH diet with soy nuts).55 Soy nut consumption reduced inflammatory markers and increased nitric oxide levels, improving endothelial function. Further analysis of the data revealed soy nut consumption also improved glycemic control and lipid profiles more than the control or soy protein diet.56 Chinese researchers conducted an intervention with 30 obese adults and found those who consumed a hypocaloric diet with only soy protein (compared to 1/3 soy and 2/3 animal protein) had greater reductions in total cholesterol and LDL cholesterol, as well as greater effects on body fat percentages.57 Researchers from the Functional Medicine Research Center, Gig Harbor, Wash., randomly assigned 59 postmenopausal overweight/obese women to the AHA Step 1 diet or a low-glycemic diet delivering 30 g/d of soy protein.58 Women on the low-glycemic/soy diet had significantly significant decreases in total cholesterol, LDL cholesterol and triacylglycerol. An important part of the Asian diet is green tea, which has antioxidant and anti-inflammatory effects, while also positively impacting atherosclerosis, hypertension and obesity.59 Boston University researchers note green tea’s flavonoids appear to positively impact endothelial function, reducing cardiovascular risk.60 In addition, green tea polyphenols are able to decrease lipid peroxidation and prevent the overproduction of pro-inflammatory cytokines.61 Of particular interest to researchers has been green tea’s most bioactive flavonoid, epigallocatechin gallate (EGCG). Italian researchers conducted an experiment in spontaneously hypertensive rats (SHR) to examine the effects of EGCG on cardiovascular and metabolic function.62 EGCG stimulated production of nitric oxide from the endothelium, improving vasodilation and lowering systolic blood pressure while also benefiting insulin sensitivity. In vitro work from the University of Dundee, Scotland, reported EGCG exerted insulin-mimetic effects, in part by phosphorylation of transcription factors.63 And researchers from the Hamner Institutes for Health Sciences, Research Triangle Park, N.C., report in isolated hepatocytes that EGCG can inhibit glucose production via gluconeogenesis.64 Researchers have also cited EGCG for its ability to reduce adipocyte proliferation, while increasing beta-oxidation and thermogenesis.65 In a pilot study conducted at Universitary Medicine Berlin, six overweight men given 300 mg/d EGCG had increased fat oxidation in adipose tissue mass.66 Thai researchers reported similar findings in their trial involving 60 obese men, in which green tea increased energy expenditure and fat oxidation.67 A trial in 76 over weight women, conducted at Maastricht University, Netherlands, also found providing 270 mg/d EGCG plus 150 mg/d caffeine increased weight loss through thermogenesis and fat oxidation and with suppressed leptin.68
Share this article: Email,
Slashdot, Digg,
Del.icio.us, Yahoo!MyWeb,
Windows Live Favorites,
Furl
|
|
| Sponsored Links | Natural Products INSIDER Announcements |